Fibroblast growth factor receptor-2 (FGFR2) fusions account for 3.5% of the genomic alterations KRAS WT PDAC and pancreatic acinar cell carcinoma [29,70]. The gene discussed is FGFR2; the disease is pancreatic acinar cell carcinoma.